Psychiatric Manifestations of Levodopa *

Akert K. , and Anderson B. : Experimenteller Beitrag zut Physiologie des Nucleus Caudatus. Acta Physiol. Scand. 22: 281–298, 1951.

Blaschko H. , and Chrusciel T. L. : The de-carboxylation of aminoacids related to tyroxine and their awakening action in reserpine-treated mice. J. Physiol. (Lond.) 151: 272–284, 1960.

Bradley P. B. , and Wolstencroft J. H. : Actions of drugs on single neurons in the brain stem. Brit. Med. Bull. 21: 15–18, 1965.

Bunney Wm. E. Jr. , and Davis J. M. : Norepinephrine in depressive reactions (A review). Arch. Gen. Psychiat. 13: 483–494, 1965.

Cannon W. B. : Bodily Changes in Pain, Hunger, Fear and Rage. Second edition, New York, Harper and Row Publishing Company, 1963.

Celesia G. G. , and Barr A. N. : Psychosis and other psychiatric manifestations of levodopa therapy. Arch. Neurol. 23: 193, Sept. 1970.

Dean W. H. , and Davis G. D. : Behavior changes following caudate lesions in the rhesus monkey. J. Neurophysiol. 22: 524–557, 1959.

Everett G. M. : Some electrophysiological and biochemical correlates of motor activity and aggressive behavior. Proceedings of the 2nd International Meeting of the Collegium Internationale Neuro-Psychopharmacologicum, Basle, 1960. Neuropharmacology 2: 49–84, 1961.

Friedhoff A. J. , and Van Winkle E. : The characteristics of an amine found in the urine of schizophrenic patients. J. Nerv. Ment. Dis. 135: 550–555, 1962.

Harley-Mason in: Osmond H. , and Smythies J. : Schizophrenia: A new approach. J. Ment. Sci. 98: 309–315, 1952.

Hoffer A. , Osmond H. , and Smythies J. : Schizophrenia: A new approach. II. Results of a year's research. J. Ment. Sci. 100: 29–45, 1954.

Klerman G. L. , Schildkraut J. J. , Hasenbush L. L. , Greenblatt M. , and Friend D. G. : Clinical experience with dihydroxyphenylalamine (dopa) in depression. J. Psychiat. Res. I: 289–297, 1963.

Krnjevic K. , and Phillis J. W. : Actions of certain amines on cerebral cortical neurons. Brit. J. Pharmacol. 20: 471–490, 1963.

Lader M. : Comparison of amphetamine sulphate and caffeine citrate in man. Psychopharmacologia 14: 83–93, 1969.

Mettler F. A. : Perceptual capacity, functions of the corpus striatum and schizophrenia. Psychiat. Quart. 29: 89–111, 1955.

O'Malley W. E. : Pharmacology of L-Dopa. Symposium held at Georgetown University School of Medicine, Washington, D.C., Jan. 14, 1970.

Osmond H. , and Smythies J. R. : Schizophrenia: A new approach. J. Ment. Sci. 98: 309–315, 1952.

Scheel-Kruger J. , and Randrup A. : Stereo-type hyperactive behavior produced by dopamine in the absence of noradrenaline. Life Science 6: 1389–1398, 1967.

Shulgin A. T. , Sargent T. , and Naranjo C. : Structure-activity relationships of one-ring psychotomimetics. Nature 221: 537–541, 1969.

Van Buren N. M. : Confusion and disturbance of speech from stimulation in vicinity of the head of the caudate nucleus. J. Neurosurg. 20: 148–157, 1963.

Yaryura-Tobias J. A. , Diamond B. , and Merlis S. : The action of L-Dopa on schizophrenic patients (A preliminary report). Curr. Ther. Res. 12: 528–531, 1970.

Zimmerman F. T. , and Burgemeister B. B. : The effect of reserpine on the behavior problems of children. New York State J. Med. 57: 3132–3139, 1957.